Related Experiment Video
Updated: Sep 17, 2025

07:50
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
16.0K
Linking Trials to Publications: Enhancing Recall by Identifying Trial Registry Mentions in Full-Text
Arthur W Holt1, Neil R Smalheiser1
1Department of Psychiatry, University of Illinois at Chicago, Chicago, IL 60304 USA.
Medrxiv : the Preprint Server for Health Sciences
|June 30, 2025
Summary
A new tool links clinical trials to publications using machine learning and full-text searches. This improves finding clinical study results, aiding evidence synthesis and meta-science research.
Area of Science:
- Biomedical Informatics
- Clinical Trial Research
- Meta-science
Background:
- Linking clinical trials to their publications is crucial for evidence synthesis.
- Existing tools struggle to identify publications when registry numbers are not in metadata.
- Textual clues in titles or abstracts identify only a fraction of linked publications.
Purpose of the Study:
- To enhance a machine learning tool for linking clinical trials to publications.
- To improve the identification of publications reporting clinical outcome results.
- To increase the recall of linked publications by searching full-text content.
Main Methods:
- Developed a web-based tool using machine learning to predict publication links.
- Expanded the tool to search for registry numbers (NCT numbers) within full-text articles.
- Included data from PubMed Central, EuroPMC, and OpenAlex for full-text analysis.
- Retrieved biomedical citations from the ClinicalTrials.gov registry.
Main Results:
- The initial tool showed high precision but limited recall for publications without explicit metadata links.
- Searching full-text articles significantly increased the identification of linked publications.
- Retrieving citations from the registry itself further enhanced connectivity.
Conclusions:
- The expanded tool greatly improves the ability to identify publications reporting clinical trial results.
- This enhanced recall assists researchers in evidence synthesis and meta-science studies.
- The tool provides a valuable resource for understanding the dissemination of clinical trial findings.
Related Concept Videos
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials
8.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.7K
Hazard Ratio
259
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
259
Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
Nursing Clinical Information System
876
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
876
Pharmacovigilance
1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K

